Found: 13
Select item for more details and to access through your institution.
Response to: Prognostication of HCC patients under sorafenib is not always possible.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1243, doi. 10.1111/liv.14335
- By:
- Publication type:
- Article
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 215, doi. 10.1111/liv.14270
- By:
- Publication type:
- Article
Correction to: Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Eligibility for Liver Transplantation in Patients with Perihilar Cholangiocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 3, p. 1483, doi. 10.1245/s10434-020-09001-8
- By:
- Publication type:
- Article
A pilot study on hepatobiliary scintigraphy to monitor regional liver function in yttrium-90 radioembolization.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224394
- By:
- Publication type:
- Article
A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in <sup>90</sup>Y Radioembolization.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 10, p. 1430, doi. 10.2967/jnumed.118.224394
- By:
- Publication type:
- Article
Diffusion-weighted imaging of hepatocellular carcinoma before and after transarterial chemoembolization: role in survival prediction and response evaluation.
- Published in:
- Abdominal Radiology, 2019, v. 44, n. 8, p. 2740, doi. 10.1007/s00261-019-02030-2
- By:
- Publication type:
- Article
Sorafenib for Patients with Hepatocellular Carcinoma and Child‐Pugh B Liver Cirrhosis: Lessons Learned from a Terminated Study.
- Published in:
- Oncologist, 2020, v. 25, n. 9, p. e1274, doi. 10.1634/theoncologist.2019-0718
- By:
- Publication type:
- Article
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma – a substudy of the SORAMIC trial.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 9, p. 1028, doi. 10.1080/0284186X.2020.1759826
- By:
- Publication type:
- Article
Are we SHARP enough? The importance of adequate patient selection in sorafen ib treatment for hepatocellular carcinoma.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 11, p. 1467, doi. 10.1080/0284186X.2018.1479070
- By:
- Publication type:
- Article
Liver Decompensation as Late Complication in HCC Patients with Long-Term Response following Selective Internal Radiation Therapy.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5427, doi. 10.3390/cancers13215427
- By:
- Publication type:
- Article
Correction to: Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article